134 related articles for article (PubMed ID: 11916513)
1. Erythroleukemia: a comparison between the previous FAB approach and the WHO classification.
Park S; Picard F; Azgui Z; Viguie F; Merlat A; Guesnu M; Leblond V; Dreyfus F
Leuk Res; 2002 May; 26(5):423-9. PubMed ID: 11916513
[TBL] [Abstract][Full Text] [Related]
2. Erythroleukemia: a need for a new definition.
Park S; Picard F; Dreyfus F
Leukemia; 2002 Aug; 16(8):1399-401. PubMed ID: 12145675
[TBL] [Abstract][Full Text] [Related]
3. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
[TBL] [Abstract][Full Text] [Related]
4. Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes.
Calvo X; Arenillas L; Luño E; Senent L; Arnan M; Ramos F; Ardanaz MT; Pedro C; Tormo M; Montoro J; Díez-Campelo M; Arrizabalaga B; Xicoy B; Bonanad S; Jerez A; Nomdedeu B; Ferrer A; Sanz GF; Florensa L
Mod Pathol; 2016 Dec; 29(12):1541-1551. PubMed ID: 27562492
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features and outcome of acute erythroid leukemia based on 2008 revised World Health Organization classification.
Liu CJ; Hong YC; Yang CF; Liu SH; Gau JP; Liu JH; Hsiao LT; Liu CY; Yu YB; Tzeng CH
Leuk Lymphoma; 2012 Feb; 53(2):289-94. PubMed ID: 21780998
[TBL] [Abstract][Full Text] [Related]
6. Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease.
Kasyan A; Medeiros LJ; Zuo Z; Santos FP; Ravandi-Kashani F; Miranda R; Vadhan-Raj S; Koeppen H; Bueso-Ramos CE
Mod Pathol; 2010 Aug; 23(8):1113-26. PubMed ID: 20473273
[TBL] [Abstract][Full Text] [Related]
7. Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification.
Liu W; Hasserjian RP; Hu Y; Zhang L; Miranda RN; Medeiros LJ; Wang SA
Mod Pathol; 2011 Mar; 24(3):375-83. PubMed ID: 21102413
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases.
Kowal-Vern A; Mazzella FM; Cotelingam JD; Shrit MA; Rector JT; Schumacher HR
Am J Hematol; 2000 Sep; 65(1):5-13. PubMed ID: 10936857
[TBL] [Abstract][Full Text] [Related]
9. Acute erythroid leukemia.
Zuo Z; Polski JM; Kasyan A; Medeiros LJ
Arch Pathol Lab Med; 2010 Sep; 134(9):1261-70. PubMed ID: 20807044
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological evolution and multilineage involvement in erythroleukemia: report of a case.
Cuneo A; Gretel Carli M; Piva N; Fagioli F; Vandenberghe E; Dal Cin P; Castoldi G; Van Den Berghe H
Haematologica; 1991; 76(3):235-7. PubMed ID: 1743594
[TBL] [Abstract][Full Text] [Related]
11. Minimally differentiated erythroleukaemia (AML M6 'variant'): a rare subset of AML distinct from AML M6. Groupe Français d'Hématologie Cellulaire.
Garand R; Duchayne E; Blanchard D; Robillard N; Kuhlein E; Fenneteau O; Salomon-Nguyen F; Grange MJ; Rousselot P; Demur C
Br J Haematol; 1995 Aug; 90(4):868-75. PubMed ID: 7669665
[TBL] [Abstract][Full Text] [Related]
12. Acute erythroid leukemia with <20% bone marrow blasts is clinically and biologically similar to myelodysplastic syndrome with excess blasts.
Wang SA; Patel KP; Pozdnyakova O; Peng J; Zuo Z; Dal Cin P; Steensma DP; Hasserjian RP
Mod Pathol; 2016 Oct; 29(10):1221-31. PubMed ID: 27443511
[TBL] [Abstract][Full Text] [Related]
13. Pure erythroid leukemia.
Wang W; Wang SA; Medeiros LJ; Khoury JD
Am J Hematol; 2017 Mar; 92(3):292-296. PubMed ID: 28006859
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of proerythroblasts in acute erythroleukemia.
Kowal-Vern A; Cotelingam J; Schumacher HR
Am J Clin Pathol; 1992 Jul; 98(1):34-40. PubMed ID: 1615923
[TBL] [Abstract][Full Text] [Related]
15. Mixed colony formation composed of erythroblasts and myeloblasts by leukemic blast progenitors in patients with erythroleukemia.
Nara N; Tanikawa S; Shiina S
Exp Hematol; 1993 Jan; 21(1):98-102. PubMed ID: 8417964
[TBL] [Abstract][Full Text] [Related]
16. [Evolution to megakaryoblastic leukemia observed in myelodysplastic syndrome with erythrolekemia-like features].
Takai K; Sanada M; Shibuya H
Rinsho Ketsueki; 1992 Aug; 33(8):1071-6. PubMed ID: 1404864
[TBL] [Abstract][Full Text] [Related]
17. The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease.
Goldberg SL; Noel P; Klumpp TR; Dewald GW
Am J Clin Oncol; 1998 Feb; 21(1):42-7. PubMed ID: 9499256
[TBL] [Abstract][Full Text] [Related]
18. Malignant and reactive erythroblasts in erythroleukemia (M6).
Bernheim A; Berger R; Daniel MT; Valensi F; Flandrin G
Cancer Genet Cytogenet; 1983 Sep; 10(1):1-10. PubMed ID: 6576849
[TBL] [Abstract][Full Text] [Related]
19. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study.
Davey FR; Abraham N; Brunetto VL; MacCallum JM; Nelson DA; Ball ED; Griffin JD; Baer MR; Wurster-Hill D; Mayer RJ
Am J Hematol; 1995 May; 49(1):29-38. PubMed ID: 7741135
[TBL] [Abstract][Full Text] [Related]
20. Erythroleukemia: a review of 15 cases meeting 1985 FAB criteria and survey of the literature.
Atkinson J; Hrisinko MA; Weil SC
Blood Rev; 1992 Dec; 6(4):204-14. PubMed ID: 1486289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
